Cogility Software Corporation – Trademark Portfolio
Entity Type: 03
Cogility Software Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TACITRED and COGILITY SOFTWARE. The owner is based in Irvine, CA.
15495 Sand Canyon Ave, Suite 150
Irvine, CA 92618
Showing of trademarks Trademarks
Trademark Classifications
Cogility Software Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Cogility Software Corporation have?
Cogility Software Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does Cogility Software Corporation file in?
Cogility Software Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Cogility Software Corporation's most well-known trademarks?
Cogility Software Corporation's registered trademark portfolio includes well-known marks such as TACITRED and COGILITY SOFTWARE. These are among 2 currently registered trademarks in the portfolio.
What is Cogility Software Corporation's trademark registration success rate?
Cogility Software Corporation has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.